Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emergence of multidrug-resistant <i>Mycobacterium tuberculosis</i> of the Beijing lineage in Portugal and Guinea-Bissau: a snapshot of moving clones by whole-genome sequencing.

Emerging microbes & infections·2020
Same author

Author Correction: Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase.

Scientific reports·2020
Same author

Machine Learning Predicts Accurately <i>Mycobacterium tuberculosis</i> Drug Resistance From Whole Genome Sequencing Data.

Frontiers in genetics·2019
Same author

Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs.

Genome medicine·2019
Same author

Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing.

American journal of respiratory and critical care medicine·2019
Same author

Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase.

Scientific reports·2018

Related Experiment Video

Updated: Jul 8, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Multidrug-resistant tuberculosis.

Ellen M Zager1, Ruth McNerney

  • 1London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. emzager@hotmail.com

BMC Infectious Diseases
|January 29, 2008
PubMed
Summary
This summary is machine-generated.

Multidrug-resistant tuberculosis (MDR-TB) surveillance needs to include population data. Current methods underestimate the threat of MDR-TB in regions like sub-Saharan Africa, highlighting a critical need for revised global health strategies.

More Related Videos

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Related Experiment Videos

Last Updated: Jul 8, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Global Health

Background:

  • Tuberculosis (TB) remains a significant global health challenge, with nearly 9 million new cases annually.
  • The emergence of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) poses a severe threat to control efforts worldwide.
  • Current epidemiological surveillance methods for drug-resistant TB may not accurately reflect the true scale of the problem.

Purpose of the Study:

  • To evaluate the adequacy of current methods for describing the epidemiology of drug-resistant TB.
  • To advocate for the inclusion of population-based statistics in global surveillance data for drug-resistant TB.
  • To re-appraise the global burden of MDR-TB, particularly in underrepresented regions.

Main Methods:

  • Analysis of existing global surveillance data for drug-resistant tuberculosis.
  • Comparison of prevalence metrics (proportion of cases vs. proportion of population).
  • Re-evaluation of MDR-TB incidence in specific regions, considering population density.

Main Results:

  • Traditional surveillance often presents drug-resistant TB as a proportion of existing TB cases, potentially masking the true population-level risk.
  • Regions like Eastern Europe and China show high proportions of MDR-TB cases.
  • When viewed through a population-based lens, sub-Saharan Africa exhibits among the highest rates of transmitted MDR-TB, indicating a more critical situation than previously perceived.

Conclusions:

  • Current global surveillance for drug-resistant TB is inadequate for resource allocation and effective control planning.
  • Incorporating population-based incidence rates is crucial for a comprehensive understanding of the MDR-TB epidemic.
  • The burden of transmitted MDR-TB in sub-Saharan Africa is significantly underestimated by current surveillance, necessitating urgent attention and targeted interventions.